Internal Advisory Board

The IAB reviews the activities of the CBID twice a year and makes recommendations to the PI and Co-I for changes in the management and focus of the Program. The meetings of the IAC are at alternate six-month intervals from those of the EAC. The advice of the IAB is not meant to supplant that of the EAC, only to offer an additional period of review and assessment of meeting the milestones set at the beginning of each Project Grant or of the Cores. The advice of the IAB is discussed with the EAC and the recommendations of the two committees implemented.

Internal Advisory Board Members

Susan Lunte
  • Distinguished Professor Pharmaceutical Chemistry and Chemistry
  • Director, R.N. Adams Institute for Bioanalytical Chemistry
  • Director, COBRE Center on Molecular Analysis of Disease Pathways
  • University of Kansas

Scott Weir
  • Professor, Cancer Biology Department, KUMC
  • Director, Institute for Advancing Medical Innovation, University of Kansas
  • Associate Director - Translational Research, University of Kansas Cancer Center
  • Kelly Family Endowed IAMI Professor in Cancer Drug Discovery and Development